2026 Q3 Portfolio Activity
In 2026 Q3, Versant Venture Management, LLC maintained a portfolio of 8 distinct positions. They heavily accumulated shares in Contineum Therapeutics, Inc., increasing the position by 138.2%. The fund also reduced its exposure to Skye Bioscience, Inc. by 87.5%.
Position History
hover any row below to update
Loading…
Total Positions
8
Quarter
2026 Q3
Top Holding
GLUE (34.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8
Versant Venture Management, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GLUE
Monte Rosa Ther...
|
Healthcare | 34.78% | 47.34% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
3,180,780 | $37,946,705 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IPSC
Century Therape...
|
Healthcare | 19.07% | 18.33% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
12,166,109 | $20,804,046 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CTNM
Contineum Thera...
|
Healthcare | 15.90% | 5.47% |
#3
2
Prev: #5
|
8.0 |
—
|
750,000 | 138.2% |
P
S
|
1,292,628 | $17,347,068 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
JBIO
Jade Bioscience...
|
Healthcare | 12.77% | 13.55% |
#4
1
Prev: #3
|
5.5 |
—
|
no change | no change |
P
S
|
991,783 | $13,934,551 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
LENZ
Lenz Therapeuti...
|
Healthcare | 9.35% | 9.28% |
#5
1
Prev: #4
|
5.2 |
—
|
no change | no change |
P
S
|
2,656,888 | $10,202,450 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CRSP
CRISPR Therapeu...
|
Healthcare | 7.55% | 4.99% |
#6
Prev: #6
|
4.0 |
—
|
no change | no change |
P
S
|
148,831 | $8,233,331 | 2018 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SKYE
Skye Bioscience...
|
Healthcare | 0.37% | 0.86% |
#7
Prev: #7
|
0.1 |
—
|
-1,756,742 | -87.5% |
P
S
|
250,962 | $404,049 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
N/A
Tempest Therape...
|
|
Unknown | 0.21% | 0.18% |
#8
Prev: #8
|
1.1 |
—
|
no change | no change |
P
S
|
269,772 | $225,071 | — | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-8 of 8 holdings